AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...

Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s ...

Millions of Americans will tune into the 2025 Super Bowl on Sunday not only to watch the championship game, but also to check out the big-budget commercials from some of the nation's biggest ...

Not only are people excited to watch the football game and cheer on their favorite team, they are eager to see the commercials too. An Ipsos survey conducted in December found that nearly 80% of ...

It's the one day of the year people don't complain about commercials. OK, that's not true. People will certainly be complaining Sunday about the commercials, but it will be because of the very ...

When it comes to live television, DVR recordings made it possible to skip the commercials without much effort. Many streaming services offer the ability to pay extra each month to avoid being ...

Jordan" television commercial for Super Bowl XXVII in September, 1992 in Los Angeles, California. Each year, the Super Bowl draws upward of 100 million eyeballs—Super Bowl LVIII 2024 was the ...

The snacking giant, part of PepsiCo., will run a minute-long Super Bowl commercial for its flagship Lay’s that will try to do for potatoes in the Big Game what Budweiser has done for Clydesdale ...

The network has sold at least 10 of its Super Bowl commercial spots for upward of $8 million each, a person with direct knowledge of the matter confirmed to CNN.The $7 million figure was already a ...

Down the Road Spice Co., a local company inspired by a cookbook passed down from generation to generation, will be showcased during the iconic Super Bowl commercials. Owner Mansi Shah said the ...

This makes the new indication for Dupixent very important for Sanofi as it searches for a blockbuster to transform its fortunes. The FDA is set to make a decision on Dupixent’s new indication on ...